INTRODUCTION {#s1}
============

Epithelial ovarian cancer (EOC) is the most lethal gynecological cancer and the fifth most common cause of cancer-related death among women in the United States \[[@R1]\]. Serous ovarian cancer (SOC), peritoneal carcinoma, carcinosarcoma, and mixed carcinoma with serous component account for 78% of all cases and 87% of advanced stage cases of EOC \[[@R2]\]. SOC is the most common histological subtype of EOC. Due to latent symptoms and lack of reliable early screening methods, most SOCs are diagnosed at an advanced stage (stage III-IV; International Federation of Gynecology and Obstetrics, FIGO) \[[@R3]\]. As advanced-stage or high-grade SOCs are more likely to have a poor prognosis \[[@R4]\], discovering gene expression signatures associated with SOC stage and grade outcomes is crucial.

Previous integrated genomic analyses of ovarian carcinoma subdivided SOCs into multiple molecular subtypes and attempted to explain their association with prognosis \[[@R5]--[@R7]\]. However, some of the SOC subtypes proposed by Tothill et al. were mixed with endometrioid ovarian cancers \[[@R6]\], while those defined by Verhaak et al. contained only high-grade SOCs \[[@R7]\]. In the above studies, researchers established tumor subtypes based on inherent gene expression profiles and then explored their relationship to clinical features, but few direct correlations were detected. From a clinical point of view, an applicable subtype system based on gene-related prognosis that can guide clinical therapeutic strategies is desirable. Recent advances in gene interaction network methodologies encouraged researchers to investigate possible intrinsic links between functional gene clusters (i.e. functional modules) and prognostic factors. Identification of meaningful modules related to grade and stage could be beneficial for inferring tumor mechanism, predicting patient survival, and establishing novel diagnostic or therapeutic targets. A weighted gene co-expression network analysis (WGCNA) was proposed to reconstruct robust gene co-expression networks (modules). These modules were constructed in terms of large-scale gene expression profiles and the distinction of centrally located genes (hub genes) that drive key cellular signaling pathways \[[@R8], [@R9]\]. The WGCNA approach has provided functional interpretation tools in systems biology and led to new insights into the pathophysiology of breast cancer and endometrial cancer \[[@R9]--[@R14]\]. Although WGCNA has been applied to detect TP53 missense or null mutations in ovarian cancer \[[@R15]\], there are no reports applying WGCNA to systematically identify gene co-expression networks associated with clinical-pathological factors in SOCs.

To fulfill this gap, we conducted a WGCNA and calculated module-trait correlations based on three public microarray datasets (GSE26193, GSE9891, and TCGA), which included 788 samples and 10402 genes. This approach identified meaningful co-expression modules significantly related to tumor grade and stage, and revealed hub genes contributing to extracellular matrix interactions and mitosis in SOC. Our study provides a novel and broad application platform for the identification of SOC gene signatures, and may be useful to characterize new molecular targets and develop effective therapeutic strategies.

RESULTS {#s2}
=======

Construction of gene co-expression network {#s2_1}
------------------------------------------

WGCNA was performed to identify gene co-expression networks associated with SOC clinical-pathological factors. Three SOC datasets, namely, GSE26193, GSE9891, and TCGA, were adopted from the curatedOvarianData Bioconductor package (Table [1](#T1){ref-type="table"}) \[[@R16], [@R17]\]. In total, 788 samples and 10402 genes were included, and ten arbitrary datasets, each containing 50% of all samples, were built through random sampling. Gene co-expression networks were then built among these ten datasets (d1 to d10). As 3 is the lowest value that allows achieving more than 90% similarities in topology models of ten datasets (Figure [1A](#F1){ref-type="fig"}), a soft threshold of 3 was implemented, resulting in the detection of 54 significant modules (Figure [1B](#F1){ref-type="fig"}).

###### General information of involved three modeling and five validation datasets

  datasets                  platform                                Involved samples   Grade (I/II/III)   Stage (I/II/III/IV)   Recurrence Status (N/Y)   Vital status (N/Y)
  ------------------------- --------------------------------------- ------------------ ------------------ --------------------- ------------------------- --------------------
  **Modeling datasets**                                                                                                                                   
   GSE26193                 hgu133plus2                             79                 4/19/56            11/6/48/14            16/63                     19/60
   GSE9891                  hgu133plus2                             237                7/86/144           11/9/195/21           62/175                    126/111
   TCGA                     hthgu133a                               472                6/58/408           13/24/365/68          225/247                   218/254
  **Validation datasets**                                                                                                                                 
   GSE17260                 hgug4112a                               110                26/41/43           0/0/93/17             34/76                     64/46
   TCGA.RNASeqV2            RNASeq                                  261                1/28/226           0/18/209/33           123/138                   114/143
   GSE20565                 hgu133plus2                             140                6/27/63            18/9/52/15            \-                        \-
   PMID15897565             hgu133a                                 63                 2/35/25            7/4/48/4              \-                        \-
   GSE49997                 ABI Human Genome Survey Microarray V2   204                0/50/143           0/9/154/31            70/124                    137/57

![Weighted gene co-expression network of SOC\
(**A**) Network topology analysis was employed to choose a soft-thresholding power to achieve scale-free topology in all modeling sets. (**B**) Fifty-four significant co-expression gene modules shared in ten random sampling sets were detected with WGCNA. Consensus gene dendrogram and module colors denote correspondence. (**C**) Correlation values of blue and ivory module-trait relationships across ten random sampling datasets. (**D**) Correlation values of yellow and white module-trait relationships across ten random sampling datasets. (**E**) *P* values of module-trait relationships of two stage-associated and two grade-associated modules across ten random sampling datasets (*p* \< 0.05).](oncotarget-08-42983-g001){#F1}

Calculation of module-trait correlations in SOCs {#s2_2}
------------------------------------------------

For each module, we calculated correlations between gene expression and clinical features such as tumor stage, grade, recurrence time, vital time, recurrence status, and vital status. The last four features were regarded as prognostic traits. Consensus module-trait relationships across the ten sets were also presented as mutually significant correlations (*p* \< 0.05). We noticed that there were multiple modules associated with one or more traits. In particular, there were consistent correlations among the ten sets in four modules, each named after their representative color: blue, ivory, yellow, and white. For instance, the blue and the ivory modules were related to tumor stage; the yellow module was related to grade; and the white module was related to grade in nine out of ten sets. Besides, correlations between gene expression patterns and prognostic traits were found in a minority of the ten sets. In short, two stage-associated and two grade-associated gene modules were identified in SOCs using WGCNA. The correlation indexes are shown in [Supplementary Figure 1](#SD1){ref-type="supplementary-material"}, and the significance of module-trait relationships is shown in Figure [1C--1E](#F1){ref-type="fig"}).

Module preservation analysis {#s2_3}
----------------------------

A summarized Z score was calculated to determine universal module preservation using WGCNA R software. Modules with a Z score \> 10 were regarded as highly preserved. As recommended by the WGCNA author, all uncharacterized genes were assigned to the gray module, which should have a Z score lower than that of most other modules \[[@R18]\]. We could assert that 36/54 modules were highly conserved ([Supplementary Table 1](#SD2){ref-type="supplementary-material"}). The Z scores of the gray module and the four stage-associated or grade-associated modules were 78.82 (blue), 61.51 (yellow), 30.3 (white), 30.0 (gray) and 27.41 (ivory). The blue module was regarded as a representative stage-associated module and the yellow module as a grade-associated module, because they both contained higher conservation and consistent association with stage or grade. [Supplementary Table 2](#SD3){ref-type="supplementary-material"} contains gene symbols inside these four modules.

Identification of universal hub genes in the blue and yellow modules {#s2_4}
--------------------------------------------------------------------

The blue and yellow modules comprised 884 and 561 genes, respectively. Genes with the top 200 strongest connections within the blue and yellow modules from each set were extracted to show their connections and identify hub genes ([Supplementary Figures 2 and 3](#SD1){ref-type="supplementary-material"}). Within each network, node sizes, font sizes, and color depth are proportional to their connectivity (sum of in-module degrees). Shared hub genes were readily discernible in all ten sets.

To compare and integrate our gene co-expression networks with protein interaction data, we extracted a high-quality protein interaction network from the Search Tool for the Retrieval of Interacting Genes (STRING), which only contains interactions with a combined score above 600. The retrieved STRING network contained 16771 nodes and 392611 edges. Nodes were defined as individual genes in the network, and edges were defined as the interactions between genes. Subsequently, we found mutual genes in each module and in the STRING network gene set and extracted them from the respective subnetworks. As shown in Figures [2A](#F2){ref-type="fig"} and [3A](#F3){ref-type="fig"}, the blue module subnetwork contained 505 nodes and 2093 edges, while the yellow module subnetwork contained 313 nodes and 2215 edges. Since the subnetworks were extracted from a high-quality STRING protein interaction database section, derived from traceable interaction experiments, the data suggest that a tight regulatory relationship exists for these module genes in nature.

![Blue module gene network and enrichment analysis\
(**A**) Top hub genes of the blue module are shown in blue; gene importance was assigned according to circle diameter and color depth, in descending order. Intersection of the top 25 hub genes with the high-quality STRING network is shown in red. COL16A1 is shown in green as a node connected to MMP2 and COL. (**B**) Gene ontology and pathway enrichment analysis of blue module genes.](oncotarget-08-42983-g002){#F2}

![Yellow module gene network and enrichment analysis\
(**A**) Top hub genes of the yellow module are shown in yellow; gene importance was assigned according to circle diameter and color depth, in descending order. Intersection of the top 25 hub genes with the high-quality STRING network is shown in red. FOXM1 is shown in green as a node connected to CDK1 and CENPA. (**B**) Gene ontology and pathway enrichment analysis of yellow module genes.](oncotarget-08-42983-g003){#F3}

A comparison of the top 25 hub genes throughout the co-expression network among the ten datasets, and mutual subnetwork genes, is summarized in Table [2](#T2){ref-type="table"} (blue module) and Table [3](#T3){ref-type="table"} (yellow module). In the blue module co-expression network, MMP2, COL1A2, and COL3A1 were hub genes with tight relationships. MMP2 interacted with COL1A2 or COL3A1 through COL16A1 (Figure [2A](#F2){ref-type="fig"}). In the yellow module co-expression network, CDK1 interacted with CENPA through FOXM1, while CENPA, CDC20, AURKB, BUB1, BUB1B, and BIRC5 interacted with each other directly (Figure [3A](#F3){ref-type="fig"}). The regulatory networks among these hub genes, although complex, were organized in a similar topology.

###### The top 25 hub genes of the blue module through ten datasets and the high-quality STRING subnetwork

  Number   d1                  d2                  d3                d4                  d5                  d6                  d7                  d8                  d9                  d10                 STRING_600
  -------- ------------------- ------------------- ----------------- ------------------- ------------------- ------------------- ------------------- ------------------- ------------------- ------------------- -------------------
  1        FBN1                FBN1                FBN1              FBN1                FBN1                FBN1                FBN1                FBN1                FBN1                FBN1                JUN
  2        COL5A1              COL5A1              COL5A1            COL5A2              COL5A1              COL5A1              COL5A1              COL5A2              COL5A2              COL5A2              BMP4
  3        COL5A2              AEBP1               AEBP1             COL5A1              COL5A2              COL5A2              COL5A2              COL5A1              COL5A1              COL5A1              BMP2
  4        AEBP1               COL5A2              COL5A2            AEBP1               AEBP1               AEBP1               AEBP1               AEBP1               AEBP1               AEBP1               **MMP2**
  5        FAP                 SPARC               INHBA             SPARC               FAP                 FAP                 SNAI2               SPARC               FAP                 SPARC               ITGB1
  6        SPARC               SNAI2               FAP               FAP                 SPARC               **MMP2**            FAP                 FAP                 SNAI2               FAP                 FOS
  7        [**MMP2**]{.ul}     [**MMP2**]{.ul}     SPARC             [**MMP2**]{.ul}     INHBA               SNAI2               SPARC               INHBA               SPARC               **MMP2**            NOTCH1
  8        SNAI2               FAP                 [COL3A1]{.ul}     INHBA               [**MMP2**]{.ul}     CTSK                INHBA               [**MMP2**]{.ul}     INHBA               INHBA               IGF1
  9        INHBA               INHBA               SNAI2             SNAI2               CTSK                INHBA               [**MMP2**]{.ul}     SNAI2               [**MMP2**]{.ul}     SNAI2               KDR
  10       VCAN                ADAM12              [**MMP2**]{.ul}   VCAN                SNAI2               SPARC               CTSK                VCAN                VCAN                CTSK                IL6
  11       CRISPLD2            CTSK                CTSK              CTSK                [COL3A1]{.ul}       VCAN                LOX                 CTSK                CTSK                [COL3A1]{.ul}       FN1
  12       [COL3A1]{.ul}       VCAN                VCAN              [COL3A1]{.ul}       VCAN                [COL3A1]{.ul}       [COL3A1]{.ul}       [COL3A1]{.ul}       [COL3A1]{.ul}       VCAN                CAV1
  13       ADAM12              [COL3A1]{.ul}       CRISPLD2          ADAM12              ADAM12              CRISPLD2            VCAN                ADAM12              ACTA2               COL11A1             THBS1
  14       CTSK                COPZ2               ADAM12            [**COL1A2**]{.ul}   CRISPLD2            ADAM12              ADAM12              CRISPLD2            CRISPLD2            ZEB1                [**COL1A2**]{.ul}
  15       LOX                 COL6A3              COL6A3            COL6A3              COL11A1             COL6A3              PDLIM3              [**COL1A2**]{.ul}   ADAM12              LOX                 EGR1
  16       [**COL1A2**]{.ul}   CRISPLD2            LOX               CRISPLD2            LOX                 ZEB1                CRISPLD2            COL6A3              PDLIM3              ADAM12              ESR1
  17       COL6A3              [**COL1A2**]{.ul}   COPZ2             CDH11               SERPINF1            LOX                 SERPINF1            BGN                 COPZ2               ACTA2               ITGB5
  18       COL11A1             SERPINF1            COL11A1           ACTA2               ECM1                [**COL1A2**]{.ul}   ACTA2               LOX                 [**COL1A2**]{.ul}   CRISPLD2            MMP1
  19       CDH11               BGN                 ACTA2             SERPINF1            LRRC15              COL11A1             COL6A3              SERPINF1            ZEB1                COL6A3              SERPINE1
  20       PDLIM3              CDH11               PDLIM3            COL11A1             ANGPTL2             SERPINF1            ECM1                OLFML2B             COL6A3              PDLIM3              [COL3A1]{.ul}
  21       ZEB1                ZEB1                CDH11             PDLIM3              COL6A3              GLT8D2              GLT8D2              CDH11               COL11A1             CDH11               MMP14
  22       COL6A2              LOX                 LRRC15            ECM1                PDLIM3              ECM1                COL11A1             FN1                 SERPINF1            COL10A1             DCN
  23       SERPINF1            COL11A1             FN1               OLFML2B             [**COL1A2**]{.ul}   COPZ2               COPZ2               COL11A1             LOX                 SERPINF1            COL4A1
  24       LHFP                PDLIM3              PDGFRB            LRRC15              COL10A1             CDH11               [**COL1A2**]{.ul}   ACTA2               ECM1                [**COL1A2**]{.ul}   SHC1
  25       ANGPTL2             EDNRA               ECM1              GLT8D2              ACTA2               PDLIM3              LHFP                PDLIM3              CDH11               ECM1                HIF1A

d1--d10: ten datasets sampled from the modeling datasets.

###### The top 25 hub genes of the yellow module through ten datasets and the high-quality STRING subnetwork

  number   multi1             multi2             multi3             multi4             multi5             multi6             multi7             multi8             multi9             multi10            STRING_600
  -------- ------------------ ------------------ ------------------ ------------------ ------------------ ------------------ ------------------ ------------------ ------------------ ------------------ ------------------
  1        TPX2               TPX2               TPX2               KIF4A              TPX2               TPX2               TPX2               KIF4A              KIF4A              KIF4A              [CDK1]{.ul}
  2        [CENPA]{.ul}       KIF4A              [CENPA]{.ul}       [CENPA]{.ul}       [**BUB1**]{.ul}    KIF4A              [CENPA]{.ul}       [CENPA]{.ul}       [CENPA]{.ul}       TPX2               PLK1
  3        DLGAP5             [CENPA]{.ul}       KIF4A              TPX2               KIF4A              NUSAP1             DLGAP5             TPX2               TPX2               NUSAP1             PCNA
  4        KIF4A              [**BUB1**]{.ul}    MELK               [**BUB1**]{.ul}    RACGAP1            KIF15              KIF4A              [**BUB1**]{.ul}    [**BUB1**]{.ul}    [CENPA]{.ul}       CDK2
  5        [**BUB1**]{.ul}    MELK               [**BUB1**]{.ul}    UBE2C              DLGAP5             HJURP              [**BUB1**]{.ul}    NUSAP1             DLGAP5             MELK               CCNB1
  6        NUSAP1             DLGAP5             NUSAP1             MELK               MELK               [**BUB1**]{.ul}    UBE2C              KIF15              MELK               [**BUB1**]{.ul}    [CDC20]{.ul}
  7        KIF15              NUSAP1             HJURP              RACGAP1            UBE2C              [CENPA]{.ul}       NUSAP1             DLGAP5             RACGAP1            KIF15              [AURKB]{.ul}
  8        NCAPH              UBE2C              RACGAP1            NCAPH              [CENPA]{.ul}       NCAPH              KIF15              UBE2C              KIF15              DLGAP5             AURKA
  9        UBE2C              ASPM               ASPM               KIF15              NUSAP1             MELK               NCAPH              MELK               HJURP              CCNB2              MAD2L1
  10       RACGAP1            HJURP              NCAPH              ASPM               KIF15              DLGAP5             MELK               RACGAP1            UBE2C              HJURP              MCM5
  11       ASPM               KIF15              DLGAP5             CCNB2              KIF23              RACGAP1            CCNB2              HJURP              CCNB2              [BIRC5]{.ul}       CDC6
  12       HJURP              CCNB2              KIF15              HJURP              [BIRC5]{.ul}       UBE2C              HJURP              ASPM               ASPM               RACGAP1            BUB1
  13       KIF23              RACGAP1            [**BUB1B**]{.ul}   DLGAP5             [**BUB1B**]{.ul}   ASPM               RACGAP1            [**BUB1B**]{.ul}   NUSAP1             [**BUB1B**]{.ul}   TOP2A
  14       MELK               [**BUB1B**]{.ul}   UBE2C              NUSAP1             ASPM               [**BUB1B**]{.ul}   KIF23              NCAPH              [**BUB1B**]{.ul}   ASPM               [**BUB1B**]{.ul}
  15       KIF20A             NCAPH              KIF20A             [BIRC5]{.ul}       HJURP              ZWINT              [BIRC5]{.ul}       ZWINT              NCAPH              UBE2C              BIRC5
  16       [AURKB]{.ul}       NCAPG              [AURKB]{.ul}       KIF23              PRC1               PRC1               [**BUB1B**]{.ul}   KIF23              KIF23              KIF23              CKAP5
  17       [**BUB1B**]{.ul}   KIF20A             KIF23              TTK                NCAPH              CCNB2              KIF20A             NCAPG              [BIRC5]{.ul}       KIF20A             ESPL1
  18       PRC1               [CDK1]{.ul}        [BIRC5]{.ul}       [**BUB1B**]{.ul}   KIF20A             KIF23              ASPM               [BIRC5]{.ul}       KIF20A             NCAPH              MCM3
  19       NCAPG              [BIRC5]{.ul}       [CDC20]{.ul}       ZWINT              NCAPG              [BIRC5]{.ul}       [CDK1]{.ul}        CENPF              TTK                PRC1               CCNA2
  20       [BIRC5]{.ul}       CENPF              TTK                NCAPG              CCNB2              KIF20A             NCAPG              [CDK1]{.ul}        PRC1               [CDC20]{.ul}       CCNB2
  21       CDKN3              CDCA3              NCAPG              [AURKB]{.ul}       CCNB1              CDC20              [AURKB]{.ul}       KIF20A             CDCA3              CDKN3              NDC80
  22       PTTG1              [CDC20]{.ul}       CENPF              PRC1               TTK                NCAPG              ECT2               TTK                [CDK1]{.ul}        [CDK1]{.ul}        XPO1
  23       [CDC20]{.ul}       [AURKB]{.ul}       PRC1               KIF20A             [AURKB]{.ul}       CDCA8              AURKA              PRC1               [AURKB]{.ul}       PTTG1              [CENPA]{.ul}
  24       CCNA2              CDKN3              NDC80              [CDK1]{.ul}        PTTG1              PTTG1              ZWINT              [AURKB]{.ul}       [CDC20]{.ul}       CCNB1              BRCA1
  25       TOP2A              KIF23              CDCA3              [CDC20]{.ul}       CDC20              [AURKB]{.ul}       PRC1               [CDC20]{.ul}       CEP55              TTK                CENPE

d1--d10: ten datasets sampled from the modeling datasets.

GO and pathway enrichment analysis of blue and yellow module genes {#s2_5}
------------------------------------------------------------------

To explore the biological functions of the blue and yellow modules, we performed Gene Ontology (GO) term enrichment analysis, as well as pathway ontology analyses from the KEGG, BIOCARTA, and REACTOME databases. All significant terms enriched in the above annotation systems are represented as a word cloud to facilitate comparison of the relative significance of enriched terms, where the grayscale and font size of each term are proportional to the adjusted *p value* derived from the enrichment analysis. For the blue module, the top enriched terms in GO and REACTOME pathway ontology were "extracellular matrix (ECM) organization" or "ECM structural constituent". On KEGG pathway analysis, the top enriched terms were "focal adhesion" (adjP = 6.9e-11) and "ECM-receptor interaction" (adjP = 1.0e-10) (Figure [2B](#F2){ref-type="fig"}).

For yellow module genes, the top enriched terms in the GO and pathway databases were "mitotic cell cycle," "DNA binding or replication" and "condensed chromosome kinetochore" (Figure [3B](#F3){ref-type="fig"}). Thus, the enriched terms in the annotation systems were mostly related to mitosis. These findings corroborate previous research implicating extensive cell proliferation and accelerated DNA replication as fundamental characteristics of tumor cells.

Validation of the robust correlation between blue module eigengene expression and SOC stages {#s2_6}
--------------------------------------------------------------------------------------------

For a more intuitive depiction of the the expression distribution of module genes related to SOC stages, we calculated statistical significance via Kruskal-Wallis tests and plotted the module eigengene expression distribution for stages in each modeling dataset (i.e. GSE26193, GSE9891, and TCGA). For the above cases, eigengene expression showed significant differences between stages \[Benjamini-Hochberg (BH) adjusted *p* \< 0.05\]. Meanwhile, positive correlations between eigengene expression and stages were universally demonstrated in all boxplots (Figure [4](#F4){ref-type="fig"}).

![Distributions of blue module eigengene expression among traits in modeling and validation datasets\
Overall *p*-values and pairwise *p* values are shown. (**A**) 884 genes; (**B**) top 7 genes.](oncotarget-08-42983-g004){#F4}

Since this co-expression network was identified in three public datasets and the correlation of its eigengene expression with stages in each dataset was validated, we determined if this correlation would be a universal rule across SOCs by perusing the other five independent SOC datasets from the curatedOvarianData package (GSE49997, GSE17260, TCGA.RNASeqV2, GSE20565, and PMID15897565). General information for the eight modeling or validation datasets examined is shown in Table [1](#T1){ref-type="table"}. We calculated the eigengene expressions of module genes in these five validation datasets, and estimated the expression distribution among different stages using nonparametric tests. The distribution, mean value, and statistical results are shown in Figure [4A](#F4){ref-type="fig"}. From the boxplot, we found that the eigengene expression of the blue module genes showed a statistically significant distribution within stage III and stage IV patients in GSE17260 (*p* = 0.0059) and GSE49997 (*p* = 0.0148). There were significant differences between stage II and stage III (*p* = 0.0105), as well as between stage II and stage IV (*p* = 0.0218). In the other three datasets, the *p* values were greater than 0.05 (data not shown). As fewer numbers of module genes are likely needed for clinical transformation, we attempted to use the top seven hub genes to replace the 884 blue module genes. These hub genes included MMP2, COL3A1, COL1A2, FBN1, COL5A1, COL5A2, and AEBP1. There were significant differences (with lower *p* values) between eigengene expression of the top seven hub genes and tumor stages in the three modeling datasets (*p* = 0.0003025--0.01211) and in four validation datasets (*p* = 0.0009515--0.02184) (Figure [4B](#F4){ref-type="fig"}).

Validation of the robust correlation between yellow module eigengene expression and SOC grades {#s2_7}
----------------------------------------------------------------------------------------------

Significant differences were found between the yellow module eigengene expression values and different tumor grades in all modeling and validation datasets. Similarly, positive correlations between eigengene expression and tumor grades were demonstrated in all boxplots. There were significant differences between any pair of grade 1, grade 2, and grade 3 SOC in GSE9891 (*p* = 6.43e-09) and TCGA (*p* = 7.259e-06). Meanwhile, in GSE26193 (*p* = 0.0014), GSE20565 (*p* = 0.0002), TCGA.RNASeqV2 (*p* = 8.613e-05), and PMID15897565 (*p* = 0.0065), differences appeared between grade 1 and grade 2, as well as between grade 1 and grade 3. Additionally, significant differences in eigengene expressions between grade 2 and grade 3 tumors were found in GSE17260 (*p* = 0.0329) and GSE49997 (*p* = 0.04619). We next used the top seven hub genes: CDK1, BUB1, BUB1B, BIRC5, AURKB, CENPA, and CDC20 to replace 561 yellow module genes. There were significant differences between the eigengene expression values of the top seven hub genes and tumor grades in the three modeling datasets and in four validation datasets (Figure [5B](#F5){ref-type="fig"}).

![Distributions of yellow module eigengene expression among traits in modeling and validation datasets\
Overall *p*-values and pairwise *p* values are shown. (**A**) 561 genes; (**B**) top 7 genes.](oncotarget-08-42983-g005){#F5}

DISCUSSION {#s3}
==========

In this study we integrated large-scale transcriptional profiling, incorporating three modeling datasets with 788 SOC samples, to identify robust co-expression modules associated with cancer characteristics. Our long-term goal was to provide insights into disease biology and diagnostic classification, which may cover the shortage of objectivity in postoperative pathological diagnosis and guide early-phase clinical therapeutic applications. We also determined that co-expression networks reflect causative relationships between gene-gene interactions. First, this study constructed two SOC-stage-specific (blue and ivory) and two grade-specific (yellow and white) modules based on ten random datasets sampled from 788 SOC samples. Second, we identified the shared hub genes in these ten datasets and found mutual subnetwork hub genes from the high-quality STRING protein interaction database for the blue and yellow modules. Third, we illustrated hub gene interactions and performed gene enrichment analysis on GO and pathway terms. Extracellular matrix organization genes were enriched for stage-related modules (blue), while cell cycle genes were enriched for grade-related modules (yellow). Then, we validated the correlations between module eigengene expression and tumor stages or grades in modeling datasets and other public validation datasets that were not used to build co-expression networks but showed ideal robustness.

The top hub genes within the blue module included FBN1, COL5A1, COL5A2, and AEBP1. A gene intersection set of the top 25 hub genes among the ten random sampling datasets and the high-quality STRING database contained MMP2, COL3A1, and COL1A2. The last two collagen (COL) proteins interacted with each other directly and with MMP2 through COL16A1. According to previous studies on ovarian cancer biomarkers, FBN1 and MMP2 were found to be metastasis-promoting markers that were stimulated or suppressed by Aurora-A or BRCA2. Clinically, high expression of FBN1 indicated poor disease-free survival \[[@R19]\] and overall survival \[[@R20]\]. COL5A1 and AEBP1 were also reported as metastatic signatures associated with poor overall survival in SOC \[[@R21]\]. The expression of COL3A1, COL5A2, and COL1A2 was also studied by immunocytochemistry and western blot analysis and found to be associated to drug-resistance in ovarian cancer \[[@R22]\]. ECM-receptor interaction was enriched based on the KEGG pathway in our study, while COL3A1, COL5A2, and COL2A1 were regarded as potential ECM components associated with cytostatic drug resistance in ovarian cancer cells \[[@R23]\]. Consequently, both top hub genes and intersection set genes all had close relationships with ovarian cancer, however, the exact roles of these hub genes in ovarian tumorigenesis, metastasis or drug resistance remain unknown. Our gene module co-expression network may provide clues to the complex regulatory networks between these various molecular components. Additionally, the blue module was related to different tumor stages and its eigengene expression values can be utilized as a more objective staging system to improve current clinical-pathological staging systems.

The gene intersection set of the yellow module hub genes and the high-quality STRING database contained CDK1, BUB1, BUB1B, BIRC5, AURKB, CENPA, and CDC20. The last six genes interacted with each other directly, while CDK1 interacted with CENPA through FOXM1. Cytoplasmic CDK1 overexpression was correlated with cancer growth and poor overall survival in 249 EOCs \[[@R24]\]. CDK1 was also found to be a potential target of transcription factors to regulate paclitaxel resistance in EOC patients \[[@R25]\]. While a few EOC studies implicated BUB1, BUB1B, BIRC5, AURKB, CENPA, and CDC20, multiple studies in contrast identified aberrantly increased expression of FOXM1 and its regulatory factors \[[@R26]--[@R29]\]. Overexpression of BUB1 was reported in non-small cell lung cancer \[[@R30]\] and breast cancer \[[@R31]\]. TPX2 (Targeting Protein for Xklp2), CENPA, and KIF4A were the top three hub genes in most of the ten sets. Although the function of TPX2 in EOC pathology is unknown, it was reported as a biomarker of poor survival in 143 EOC patients \[[@R32]\]. In cervical cancer, the expression of TPX2 was correlated with histological grading, FIGO staging, and lymph node metastasis \[[@R33]\]. Additionally, TPX2 was verified as a target gene of microRNA-491 in esophageal cancer and played a critical role in cancer cell invasion in both esophageal \[[@R34]\] and colon cancer \[[@R35]\]. Moreover, TPX2 was found to be a binding partner and activator of AURKA \[[@R36]\]. KIF4A, on the other hand, is critical for mitotic regulation, including chromosome condensation, spindle organization, and cytokinesis \[[@R37]\]. Abnormal expression of KIF4A induced apoptosis in breast cancer \[[@R38]\] and metastatic invasion in lung cancer \[[@R39]\]. In summary, compared with blue module hub genes, much less is known about the molecular actions of the yellow module hub genes. Research on these hub genes is imperative to fully uncover how alterations in cell differentiation relate to SOC.

Due to the high heterogeneity of gene expression profiles, it is more difficult to find shared co-expression networks across databases of ovarian cancers than it is for other types of tumors. Although some significant modules were detected among very few datasets, these modules may not provide accurate information on actual biological characteristics of tumors. In one network analysis of ovarian cancer, COL5A2, TPX2, and BIRIC5 were also identified as hub genes using the joint sparse regression model \[[@R40]\]. Another study built a Bayesian network model, which used only the TCGA dataset and 68 seed genes reported in the literature \[[@R41]\]. In another publication, WGCNA was performed based on TCGA RNA-sequencing data and only studied TP53 mutations \[[@R15]\]. To the best of our knowledge, our study is the first to construct a thorough and weighted co-expression network analysis of gene expression relationships with prognostic factors and outcome. Moreover, 788 SOC patients were used to build the WGCNA model and another 778 patients were used to validate it. Since the yellow module eigengene expression showed a negative correlation with cell differentiation and its distribution showed significant differences among distinct tumor grades, we conclude that there is some regulatory causality between hub genes expression profiles and tumor grades. This is relevant, inasmuch as high-grade SOCs entail significantly higher risk of death than low-grade ones, while the existing grading system does not reliably differentiate grade 2 from grade 1 or grade 3 patients. We speculated that hub gene expression could be used to represent a true continuum from grade 1 to 3 and reliably divide grade 2 SOCs into low-grade and high-grade groups. Our future work will further refine and validate the above classification method in multicenter prospective studies including SOC patients with various tumor grades.

MATERIALS AND METHODS {#s4}
=====================

Datasets filtering {#s4_1}
------------------

The ovarian cancer datasets were adopted from the curatedOvarianData Bioconductor package \[[@R16]\]. This package represents a manually curated data collection for gene expression meta-analysis of patients with ovarian cancer, and includes both uniformly prepared microarray data and curated and documented clinical metadata. According to our special rules, only datasets and samples that contain tumor stage and grade information, as well as survival data (recurrence status, vital status, recurrence time, and vital time) were reserved. Accordingly, GSE17260, TCGA.RNASeqV2, and GSE49997 datasets were excluded from the validation sets due to absence of stage I or stage II patient data. GSE20565 and PMID15897565 were added into the validation sets as they contained complete grade and stage information. All the datasets were originated from both microarrays platforms (hthgu133a, hgu133plus2, and hgug4112a) and RNA-seq technologies. We finally kept three modeling and five validation datasets (Table [3](#T3){ref-type="table"}). To adapt to gene co-expression network analysis, only the common genes in all 3 modeling datasets were kept. Adjustment for batch effects was performed using the ComBat method \[[@R42]\], and 788 patients were randomly sampled to form ten datasets, extracting half of the total samples each time. These ten sets were used to construct a gene co-expression network.

Gene co-expression network construction {#s4_2}
---------------------------------------

Gene co-expression network analysis was performed using the R package WGCNA \[[@R9]\]. The process is summarized as follows. First, a matrix of pairwise correlations between all pairs of genes across all selected samples was constructed. Second, we chose 3 as the proper soft-thresholding power to which co-expression similarity is raised to achieve consistent scale-free topology in multiple datasets (Figure [1A](#F1){ref-type="fig"}). Third, with the chosen power value, we performed automatic network construction and module detection with the following major parameters: maxBlockSize of 20000, minModuleSize of 40, deepSplit of 4, and mergeCutHeight of 0.25. This procedure comprised calculation of network adjacencies and topological overlap dissimilarities, followed by scaling of topological overlap matrices and calculation of consensus topological overlap. Then, we built a hierarchical clustering dendrogram of gene expression data for each dataset, and performed adaptive branch cutting to identify shared functional modules. Some modules with similar expression profiles were merged, according to pre-defined parameters (Figure [1B](#F1){ref-type="fig"}) \[[@R43]\].

Calculation of module-trait correlations and module preservation {#s4_3}
----------------------------------------------------------------

Next, we determined correlations among gene expression modules and clinical traits for each of the above ten data sets. Tumor stage and grade, as well as survival data (recurrence status, vital status, recurrence time, and vital time) were chosen as clinical traits. Modules having significant relationships with one or more traits are shown in [Supplementary Figure 1](#SD1){ref-type="supplementary-material"}. After the above procedures, modules shared in ten or nine sets were detected (Figure [1C--1E](#F1){ref-type="fig"}). Modules were labeled using a conventional color scheme.

A WGCNA integrated function (modulePreservation) was used to calculate module preservation statistics and the Z summary score (Z score) was applied to evaluate whether a module was conserved or not \[[@R19]\].

Calculation of eigengene expression {#s4_4}
-----------------------------------

In the co-expression network, the first principal component (PC) of each module\'s gene expression matrix is referred to as the module eigengene (ME), a single value that represents the highest percent of variance for expression values for all module genes in a sample \[[@R44]\]. Thus, the expression profiles of module genes can be summarized as the expression profile of MEs. For convenience, ME expressions were used to discuss the correlation of gene expression modules with clinical traits. Moreover, module similarities can be measured with MEs, and some modules with high similarities can be merged according to a predefined threshold. Expression distribution differences in ME among multiple tumor grades or stages were calculated via nonparametric Kruskal-Wallis tests based on a null distribution inferred from permutation. If statistical significance existed among grades or stages, pairwise differences were estimated by Tukey\'s HSD tests, and pairwise *p* values adjusted by the BH method (Figures [4](#F4){ref-type="fig"}, [5](#F5){ref-type="fig"}).

Hub gene identification {#s4_5}
-----------------------

To evaluate the interactions of module genes and identify hub genes in each dataset, we calculated their in-module connectivity from the scale-free, weighted gene co-expression networks established in the ten sets as defined above. The connectivity of one node was defined as the sum of correlation coefficients with other nodes in a 'signed' topological overlap matrix (TOM) based on an adjacency matrix. For illustration purposes, we only extracted the top 200 strongest connections within the blue and yellow modules from each set to show the distribution of hub genes ([Supplementary Figures 2 and 3](#SD1){ref-type="supplementary-material"}).

Furthermore, we extracted a subnetwork with module genes from the high quality STRING protein interaction database (combined score ≥ 600) (Figures [2A](#F2){ref-type="fig"} and [3A](#F3){ref-type="fig"}) \[[@R45]\]. Since the STRING database weights and integrates information from numerous sources, including experimental repositories, computational prediction methods and public text collections, we only parsed the high-quality part of it, hoping to get a convincing interaction subnetwork of our module genes. The subnetwork was illustrated with Gephi \[[@R46]\].

Enrichment analysis {#s4_6}
-------------------

Enrichment analysis was based on either Fisher\'s exact test or hypergeometric test using the R package dnet \[[@R47]\]. We employed the hypergeometric test to estimate enrichment significance in our modules, and the *p* values were batch-adjusted with the BH method. All the enriched terms are represented as word clouds, whit font grayscales and sizes proportional to their enrichment significance \[[@R48]\] (Figures [2B](#F2){ref-type="fig"} and [3B](#F3){ref-type="fig"}).

SUPPLEMENTARY FIGURES AND TABLES {#s5}
================================
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